Alan Meds Review

Alan Meds: a price-first option for cash-pay GLP-1 shoppers

Alan Meds is a telehealth platform built around one clear promise: get compounded GLP-1 medication into your hands for as little money as possible. If your single biggest question is "what's the cheapest legitimate way to start semaglutide or tirzepatide?", this is a provider worth a serious look. Its entry pricing starts at $99 a month, which sits well below the category median of $169, and that aggressive number is the whole reason most people land here. What you trade for that price is depth of public information — Alan Meds keeps its program details thin online, and you'll learn the specifics mostly after you engage with their intake.

How the pricing actually works

Alan Meds uses a flat-rate model, and this is genuinely one of its better features. According to the company's own FAQ, your price stays the same at every dose with no hidden fees — as your provider steps you up the dosing ladder over the months, the cost doesn't climb with it. That matters a lot with GLP-1 therapy, because most people escalate their dose over time, and plenty of competitors quietly raise your monthly bill each time they do. Here, the medication and the medical consult are bundled into the monthly figure rather than billed as a separate consult fee, so the number you see is closer to the number you actually pay.

The catch is that the cheapest tier isn't the standard injection most people picture. The lowest price buys a microdosing plan, while a full compounded injectable run costs more. So read the tier you're actually signing up for — the headline price and the standard-injection price are not the same product.

The medications and the unusual format options

Both major GLP-1 molecules are on the menu, and everything is compounded rather than brand-name — there is no Ozempic or Zepbound box here, and no brand pricing on file. Where Alan Meds gets genuinely distinctive is format. Beyond the standard weekly injection, it offers:

• Microdosing plans for both semaglutide and tirzepatide — smaller, gentler amounts aimed at people who want to ease in or who struggle with side effects at full strength
• An oral semaglutide microdosing option for those who would rather not inject at all
• Standard compounded injectable semaglutide and tirzepatide for people who want the conventional approach

That spread of choices — injectable, microdose, and oral — is unusual at this price point and is the most real differentiator Alan Meds has. Microdosing in particular appeals to a specific crowd: people who tried a normal starting dose elsewhere, got hammered by nausea, and want to restart more slowly without paying a premium for the privilege.

Where it ships and where it doesn't

Alan Meds covers 46 states plus Washington, D.C., dispensing strictly as a ship-to-your-door service — there are no clinics or pickup locations. As of editor verification, it does not serve Alaska, Hawaii, Louisiana, or Mississippi, so confirm your state is on the list before you get attached to the price. Plans include a tailored medication plan and direct access to licensed medical providers, which is the standard telehealth oversight model rather than anything boutique.

Who should choose it — and who should skip it

Choose Alan Meds if you're paying cash, you're comfortable with compounded medication, and the monthly price is the deciding factor. The flat-rate structure makes it especially friendly for anyone planning to escalate their dose over a long course, and the microdose and oral options give cautious or needle-averse starters a low-cost on-ramp that many cheaper providers don't offer.

Skip it if you want brand-name medication, if you need a provider that lays out every program detail up front, or if you simply want more transparency before you commit. The single honest knock against Alan Meds is how little it publishes publicly about how the program runs day to day — refunds, cancellation, dose-change logistics, and support response times are not spelled out clearly online, so you're partly buying on trust.

Trust and safety: a moderate-confidence read

Alan Meds has an FDA warning letter on file, covered in the regulatory notice below. It dispenses compounded GLP-1s and provides licensed-clinician oversight as part of every plan. That said, our verification confidence here is tempered rather than high: the company names no specific accredited compounding partner in its public materials, and during our most recent pricing check we noted some drift between the prices listed online and the figures on record. Compounded medication is legal and widely used, but it isn't FDA-approved the way brand drugs are, and the thin disclosure means you should do a little extra diligence yourself. See our scoring methodology for how we weigh transparency and oversight.

The bottom line

Alan Meds earns its place as a budget pick. It pairs an aggressively low starting price with a flat-rate model that won't punish you for escalating, and it offers an unusually wide set of formats — injectable, microdose, and oral — for people who want flexibility on the cheap. The price of that price is information: you'll get fewer published details than you would from a more buttoned-up competitor, and the medication is compounded, not brand. If those trade-offs sit fine with you and your state is covered, it's a strong-value entry point. If you want maximum transparency or a name-brand prescription, look elsewhere.

If you're weighing alternatives, Sunlight ($88/month) and bmiMD ($99/month) are among the closest options we track to Alan Meds.